Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients

Home » Advanced Search

Search Results for anemia

Perform Another (Advanced) Search

Related Words: anemia, anaemia, anemia, fatigue

Showing First 1000 Results within Entire Site

Limit results to show:

1. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Thomson CenterWatch Trial information A Study of NeoRecormon (Epoetin Beta) for Prevention and Treatment of Anemia in Patients With Solid Tumors Receiving Platinum-Based Chemotherapy Prone to Induce Anemia Status: Completed ...
View Page

2. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Trial information A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia Status: Completed Protocol number: BA16169 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

3. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...by Thomson CenterWatch Trial information A Study of NeoRecormon (Epoetin Beta) in Patients With Refractory Anemia Status: Completed Protocol number: ML17850 Sponsor: Roche d.o.o. Company division: Pharmaceutical Official Scientific ...
View Page

4. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...CenterWatch Trial information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol number: BA16286 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

5. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...CenterWatch Trial information A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia Status: Completed Protocol number: BA16285 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

6. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...A Study of Different Methods of Administration of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia Status: Completed Protocol number: ML18217 Sponsor: Roche Polska Sp z o.o. Company division: Pharmaceutical ...
View Page

7. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Trial information A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia. Status: Completed Protocol number: ML19382 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

8. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...CenterWatch Trial information A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia. Status: Completed Protocol number: BA16728 Sponsor: Hoffmann-La Roche Inc Company division: Pharmaceutical Official Scientific ...
View Page

9. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Study of Subcutaneous Mircera for the Maintenance Treatment of Pre-Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol number: ML20944 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

10. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Trial information A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia Status: No longer recruiting Protocol number: ML21797 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official ...
View Page

11. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Thomson CenterWatch Trial information A Study of NeoRecormon (Epoetin Beta) in Predialysis Patients With Renal Anemia Status: Completed Protocol number: ML18101 Sponsor: Roche Bulgaria EOOD Company division: Pharmaceutical Official Scientific Title ...
View Page

12. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...information ORION Study: A Study of Monthly Subcutaneous Mircera in Predialysis Patients with Chronic Renal Anemia Status: No longer recruiting Protocol number: ML21439 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official ...
View Page

13. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Status: No longer recruiting Protocol number: ML21208 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official ...
View Page

14. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia. Status: Completed Protocol number: ML20826 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

15. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...by Thomson CenterWatch Trial information A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia. Status: Terminated Protocol number: ML20828 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

16. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. Status: Completed Protocol number: ML20339 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

17. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Status: No longer recruiting Protocol number: ML20881 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official ...
View Page

18. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...information A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia. Status: No longer recruiting Protocol number: BH18387 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official ...
View Page

19. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. Status: Recruiting Protocol number: ML21904 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Official Scientific Title ...
View Page

20. Roche Trial Information: : AnemiaRoche - Clinical Trial Protocol Registry and Results
...Roche Trial Information: : Anemia Roche - Clinical Trial Protocol Registry and Results Home Home >  Registry         Search Protocol Registry Trial Results ...
...by Thomson CenterWatch Trial information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Anemia in Patients Receiving Chemotherapy Status: Completed Protocol number: ML17617 Sponsor: Roche SAS Company division: Pharmaceutical ...
View Page


Jobson Medical Information

Copyright © 2008 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.